Introduction
Nerve growth factor (NGF) transiently increases tetrahydrobiopterin (BH 4 ) content of PC 12 and PC12h cells, a subclone of PC 12, with the maximal level (about 2-fold of the control level) at 24 hour-treatment (1) . NGF also increased the activity of GTP cyclohydrolase, a regulatory enzyme in BH 4 biosynthetic pathway, of the cells. These stimulatory effects of NGF on BH 4 and GTP cyclohydrolase activity were completely blocked by actinomycin D and cycloheximide (2, 3), suggesting that BH 4 increase may be due to an induction of GTP cyclohydrolase (3). Reagents such as dibutyryl cyclic AMP (cBcAMP), forskolin and cholera toxin that elevate the intracellular cAMP level also induced transient increase in BH 4 and GTP cyclohydrolase activity of PC 12 cells (1, 3) . However, the effects of NGF and dBcAMP were additive and the action mechanisms of these agents seemed to be quite different (3).
Since BH 4 is an essential cofactor (hydrogen donor) for tyrosine hydroxylase (TH), a rate-limting enzyme in catecholamine biosynthesis, we compare the effects of these two agents, NGF and dBcAMP, which elevate BH 4 by different mechanisms, on dopa (DO) and dopamine (DA) levels of PC12h cells.
Methods
PC12h cells were cultured in the same medium as that for PCI2 (4) . Cells (5 χ 10 4 /cm 2 ) were plated on 3.5 cm dishes or 75 cm 2 flasks and were used for experiments 3 days after plating.
DO and DA were analyzed by using a HPLC/electrochemical detector (ECD, Coulochem Model 5100A) with a 4.5 χ 150 mm-column (Tosoh TSK gel ODS 80TM).
Reaction mixture for dopa decarboxylase assay contained 40 mM Hepes, pH 7.0, 1 mM DO, 100 mM pyridoxalphosphate, 2.5 mM pargyline, 5 mM EDTA and the cell sonicate (enzyme) in a total volume of 100 μΐ. The reaction was carried out at 37 °C for 30 min, and stopped by perchloric acid addition (100 μΐ χ 0.2 m). DA degrading activity was assayed by incubating the cell sonicate with 40 mM Hepes, pH 7.0, 1 }ig DA in the absence or presence of 2.5 mM pargyline in a final volume of 100 μΐ at 37 °C for 30 min. The reaction was stopped by 100 μΐ of 0.2 m perchloric acid.
Results and Discussion
Although both NGF and dBcAMP increase BH 4 level of PC12h cells (1), effects of these agents on catecholamine content were quite different (Table 1) . NGF increased both the DO and DA contents in the cells by 1.6-and 1.3-fold, respectively, of each control level. On the contrary, while dBcAMP increased DO (usually 3 -6 fold of the control), it decreased DA to a half of the control value. Then we examined the DA producing activity in whole cells by incubating them for 30 min at 37 °C with 1 mM DO in the culture medium. DA amount produced by the cells treated with dBcAMP for 20 h (27 ng/mg protein) was lower than that produced by control cells (55 ng/mg protein), suggesting the decreased DDC activity, increased DA degrading activity, or both of them for the dBcAMP effect. To test these posibilities, DDC and DA degrading activities were examined in vitro. By the treatment of the cells with 1 mM dBcAMP for 17 h, DDC activity in cell sonicate was decreased to about 70% of the control level, while the DA degrading activity was not increased (Table 2) . DDC activity was decreased by dBcAMP in a dose dependent manner and EC 50 of dBcAMP was observed at around 100 μΜ concentration. Similar effect on DDC was detected when the cells were treated with forskolin (50 μΜ) or cholera toxin (100 ng/ml), indicating that the decrease in DDC activity was caused by the elevation of intracellular cAMP level.
This decrease in DDC activity became detectable by rather long-term (e. g., more than 10 h) treatment with dBcAMP. However, cellular DA content was also decreased by relatively short-term (20 -60 min) dBcAMP treatment by which DDC was not lowered yet, and this was accompanied by the increase in DA in the medium. These results suggest that decrease in the DDC activity may not be an only mechanism for the dBcAMP effect and that cAMP may somehow modulate the DA transport process and, thereby, eventually increase DA leakage to the extracellular fluid.
